Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2005-09-12
2010-12-07
Gambel, Phillip (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S133100, C424S152100, C424S158100, C424S172100, C514S251000, C530S387100, C530S387300, C530S388100, C530S388200, C530S388230
Reexamination Certificate
active
07846442
ABSTRACT:
Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
REFERENCES:
patent: 4695459 (1987-09-01), Steinman et al.
patent: 5096906 (1992-03-01), Mandell et al.
patent: 5204329 (1993-04-01), Ackerman et al.
patent: 5260422 (1993-11-01), Clark et al.
patent: 5298396 (1994-03-01), Kotzin et al.
patent: 5317019 (1994-05-01), Bender et al.
patent: 5468481 (1995-11-01), Sharma et al.
patent: 5502066 (1996-03-01), Heinemann et al.
patent: 5580873 (1996-12-01), Bianco et al.
patent: 5656272 (1997-08-01), Le et al.
patent: 5658570 (1997-08-01), Newman et al.
patent: 5672347 (1997-09-01), Aggarwal et al.
patent: 5698195 (1997-12-01), Le et al.
patent: 5741488 (1998-04-01), Feldman et al.
patent: 5795967 (1998-08-01), Aggarwal et al.
patent: 5919452 (1999-07-01), Le et al.
patent: 5958413 (1999-09-01), Anagnostopulos et al.
patent: 5994510 (1999-11-01), Adair et al.
patent: 6015557 (2000-01-01), Tobinick et al.
patent: 6177077 (2001-01-01), Tobinick
patent: 6190691 (2001-02-01), Mak
patent: 6270766 (2001-08-01), Feldman et al.
patent: 6770279 (2004-08-01), Feldmann et al.
patent: 7138118 (2006-11-01), Le et al.
patent: 2002/0010180 (2002-01-01), Feldmann et al.
patent: 2002/0068057 (2002-06-01), Feldmann et al.
patent: 2002/0136723 (2002-09-01), Feldmann et al.
patent: 2004/0228863 (2004-11-01), Feldmann et al.
patent: 2006/0099212 (2006-05-01), Feldmann et al.
patent: A-58976/90 (1991-02-01), None
patent: 92/17649 (1992-03-01), None
patent: 93/51522 (1993-10-01), None
patent: 1997/021229 (1997-02-01), None
patent: 2003/264629 (2003-12-01), None
patent: 2021369 (1991-01-01), None
patent: 40 06 269 (1991-08-01), None
patent: 0 240 344 (1987-10-01), None
patent: 0 288 088 (1988-10-01), None
patent: 0 663 836 (1997-07-01), None
patent: 0 914 157 (2005-10-01), None
patent: 1 941 904 (2008-07-01), None
patent: 2246569 (1990-06-01), None
patent: 2 246 569 (1992-02-01), None
patent: WO 89/08460 (1989-09-01), None
patent: WO 90/15152 (1990-12-01), None
patent: WO 90/15152 (1990-12-01), None
patent: WO 91/00092 (1991-01-01), None
patent: WO 91/02078 (1991-02-01), None
patent: WO 91/10722 (1991-07-01), None
patent: WO 92/07076 (1992-04-01), None
patent: WO 92/07585 (1992-05-01), None
patent: WO 92/08474 (1992-05-01), None
patent: WO 92/11383 (1992-07-01), None
patent: WO 92/16553 (1992-09-01), None
patent: WO 93/07863 (1993-04-01), None
patent: WO 94/06476 (1994-03-01), None
patent: WO 94/08619 (1994-04-01), None
patent: WO 94/08619 (1994-04-01), None
patent: WO 95/03827 (1995-02-01), None
patent: WO 95/09652 (1995-04-01), None
patent: WO 96/33204 (1996-10-01), None
patent: WO 98/24463 (1998-06-01), None
patent: WO 98/05357 (1998-12-01), None
patent: WO 00/50079 (2000-08-01), None
U.S. Appl. No. 07/958,248, filed Oct. 8, 1992, Marc Feldmann et al.
U.S. Appl. No. 08/607,419, filed Feb. 28, 1996, Marc Feldmann et al.
Abbas, A.K., et al. (1997) “Cellular and Molecular Immunology”, 3rd ed., p. 258 (W.B. Saunders Company, Philadelphia, PA).
Abbott Laboratories Ltd. “Abbott Laboratories Receives Positive Opinion for HUMIRA Rheumatoid Arthritis Extension From European Medicines Evaluation Agency,” May 6, 2004 Press Release.
Abstract of Berchtold, P., & Seitz, M., (1996) “Immunsuppression—gratwanderung zwischen iatrogenie und therapie [Immunosuppression—a tightrope walk between iatrogenic harm and therapy],” Schweizerische medizinische Wochenschrift, vol. 126, No. 38, pp. 1,603-1,609.
Abstract of Bouchart, F., et al., (1993) “Methotrexate as rescue/adjunctive immunotherapy in infant and adult heart transplantation,” Journal of Heart and Lung Transplantation, vol. 12, No. 3, pp. 427-433 (May-Jun. 1993).
Abstract of Drachman, D.B., (1996) “Immunotherapy in neuromuscular disorders: current and future strategies,” Muscle & Nerve, vol. 19, No. 10, pp. 1,239-1,251.
Abstract of Huang, D., et al., (1992) “Effects of anti-TNF monoclonal antibody infusion in patients with hairy cell leukaemia,” British Journal of Haematology, vol. 81, No. 2, pp. 231-234.
Addendum dated Dec. 15, 2003 in connection with Australian Patent Application No. 719015 (previously 37035/97), filed Feb. 25, 1999.
Advisory Action issued Dec. 3, 2004 in connection with U.S. Appl. No. 09/754,004, filed Jan. 3, 2001.
Advisory Action issued Jan. 17, 2003 in connection with U.S. Appl. No. 08/617,737, filed May 10, 1996.
Advisory Action issued Mar. 26, 2004 in connection with U.S. Appl. No. 09/754,004, filed Jan. 3, 2001.
Advisory Action issued Mar. 31, 2004 in connection with U.S. Appl. No. 08/617,737, filed May 10, 1996.
Amended Statement of Grounds and Particulars submitted Nov. 14, 2001 in connection with Australian Patent Application No. 719015 (previously 37035/97), filed Feb. 25, 1999.
Amendment and arguments submitted Aug. 12, 2004 in connection with Japanese Patent Application No. 6-509733, filed Oct. 6, 1993.
Amendment and arguments submitted Aug. 8, 2005 in connection with Japanese Patent Application No. 5-106657, filed Mar. 10, 1994.
Amendment and arguments submitted Jan. 4, 2008 in connection with Japanese Patent Application No. 5-106657, filed Mar. 10, 1994.
Amendment submitted Apr. 19, 2005 in connection with Australian Patent Application No. 2003264629, filed Dec. 1, 2003.
Amendment submitted Apr. 2, 2002 in connection with U.S. Appl. No. 08/617,737, filed May 10, 1996.
Amendment submitted Apr. 4, 1995 in connection with European Patent Application No. 93922574.4, filed Oct. 8, 1993.
Amendment submitted Aug. 25, 1993 in connection with U.S. Appl. No. 07/958,248, filed Oct. 8, 1992.
Amendment submitted Aug. 7, 2000 in connection with U.S. Appl. No. 08/690,775, filed Aug. 1, 1996.
Amendment submitted Feb. 10, 2001 in connection with European Patent Application No. 97933799.5, filed Aug. 1, 1997.
Amendment submitted Feb. 27, 2001 in connection with European Patent Application No. 94908462.8, filed Mar. 10, 1994.
Amendment submitted Feb. 4, 2004 in connection with U.S. Appl. No. 09/754,004, filed Jan. 3, 2001.
Amendment submitted Feb. 2, 2000 in connection with Canadian Patent Application No. 2,261,630, filed Aug. 1, 1997.
Amendment submitted Jan. 20, 1999 in connection with European Patent Application No. 97933799.5, filed Aug. 1, 1997.
Amendment submitted Jan. 20, 2000 in connection with U.S. Appl. No. 09/093,450, filed Jun. 8, 1998.
Amendment submitted Jan. 29, 2002 in connection with European Patent Application No. 94908462.8, filed Mar. 10, 1994.
Amendment submitted Jan. 3, 2001 in connection with U.S. Appl. No. 09/754,004, filed Jan. 3, 2001.
Amendment submitted Jan. 31, 2008 in connection with Canadian Patent Application No. 2,146,647, filed Oct. 6, 1993.
Amendment submitted Jan. 7, 1999, in connection with U.S. Appl. No. 08/617,737, filed May 10, 1996.
Amendment submitted Jul. 26, 2004 in connection with U.S. Appl. No. 09/921,937, filed Aug. 3, 2001.
Amendment submitted Jul. 31, 2003 in connection with U.S. Appl. No. 09/093,450, filed Jun. 8, 1998.
Amendment submitted Jul. 7, 1997 in connection with U.S. Appl. No. 08/403,785, filed May 3, 1995.
Amendment submitted Jul. 8, 2004 in connection with U.S. Appl. No. 10/762,096, filed Jan. 20, 2004.
Amendment submitted Jun. 17, 2003 in connection with U.S. Appl. No. 09/754,004, filed Jan. 3, 2001.
Amendment submitted Jun. 26, 2000 in connection with European Patent Application No. 94908462.8, filed Mar. 10, 1994.
Amendment submitted Jun. 8, 1998 in connection with U.S. Appl. No. 08/690,775, filed Aug. 1, 1996.
Amendment submitted Mar. 23, 2007 in connection with Australian Patent Application No. 2003264629, filed Dec. 1, 2003.
Amendment submitted Aug. 6, 2004 in connection with U.S. Appl. No. 09/754,004, filed Jan. 3, 2001.
Amendment submitted Mar. 8, 2001 in connection with Japanese Patent Application No. 5-
Feldmann Marc
Maini Ravinder N.
Cooper & Dunham LLP
Gambel Phillip
The Mathilda and Terence Kennedy Institute of Rheumatology Trust
White John P.
LandOfFree
Methods of treating rheumatoid arthritis with an... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating rheumatoid arthritis with an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating rheumatoid arthritis with an... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4222563